← Back to Awards
NIHNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
NOVEL DIAGNOSTIC BIOMARKERS DISCOVERY AND VALIDATION FOR SELECT NEGLECTED TROPICAL DISEASES
- Institution
- KEPHERA DIAGNOSTICS, LLC, MA
- Principal investigator
- Andrew E. Levin
- Funding
- $300K
- Duration
- 2024–2025
Moonbase score
Still being scored
Abstract
This project supports novel diagnostic biomarker discovery and validation activities.
LOADING MOONBASE SCORE
Questions for Kephera Diagnostics, Llc
Kephera Diagnostics, Llc hasn't set up its Moonbase portfolio yet, so questions about this research can't be asked here.
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Kephera Diagnostics, LlcNot yet scored
Peptide-based ELISA for laboratory diagnosis of sarcoidosis
Andrew E. Levin · $978K · 2025–2028
- NIH · Kephera Diagnostics, LlcNot yet scored
Rapid Point-of-Care Assay for Diagnosis of Neurocysticercosis in Seizure Patients
Andrew E. Levin · $124K · 2025–2026
- NIH · Kephera Diagnostics, LlcNot yet scored
Diagnostic assay for congenital Chagas disease
Andrew E. Levin · $303K · 2024–2026